Walleye Trading LLC Landos Biopharma, Inc. Transaction History

Walleye Trading LLC

  • $41.2 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$0.6 - $1.5 $19,879 - $49,698
-33,132 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.44 - $5.22 $14,611 - $52,967
-10,147 Reduced 23.45%
33,132 $49,000
Q4 2021

Feb 14, 2022
BUY
$4.7 - $15.0 $203,411 - $649,185
43,279 New
43,279 $208,000

About Landos Biopharma, Inc.

LABP Quotes by TradingView
  • Ticker LABP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,254,900
  • Description
  • Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...
More about LABP
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email